The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015

References

• Kleinrock M. The use of medicines in the United States: review of 2010 report by the IMS Institute for Healthcare Informatics. 2011;1–36.
   Google Scholar
• Zoëga H, Smith A, Barozzi N. Drug utilization research in the area of analgesics and psychotropics. Chapter 28. In: M. Elseviers, B. Wettermark, A. Birna Almarsdóttir et al., editor. Drug utilization research: methods and applications. 1st ed. Vol. 2016. Chichester, West Sussex : Hoboken, NJ: John Wiley & Sons, Ltd.; 2016. p. 294–301.
   Google Scholar
• Potočnjak I, Degoricija V, Vukičević BD, et al. Cardiovascular side effects of psychopharmacologic therapy. Int J Cardiol. 2016;219:367–372.
   PubMed Web of Science ®Google Scholar
• Isacsson G. Suicide prevention - a medical breakthrough? Acta Psychiatr Scand. 2000;102:113–117.
   PubMed Web of Science ®Google Scholar
• Kralj V, Silobrčić Radić M Mentalne poremećaji u Republici Hrvatskoj [Mental diseases in the Republic of Croatia]. Hrvatski Zavod za Javno Zdravstvo, Ministarstvo Zdravlja Republine Hrvatske. Uvez, d.o.o; 2011.
   Google Scholar
• Carlsson AC, Wändell P, Ösby U, et al. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health. BMC Public Health. 2013;13(1):670.
   PubMed Web of Science ®Google Scholar
• Draganić P, Žeželić S, Oštarčević S, et al.Potrošnja lijekova u Hrvatskoj 2010–2014 (eng. Consumption of medicines in Croatia 2010–2014). Agencija za lijekove i medicinske proizvode – HALMED; 2016.
   Google Scholar
• Katalinić D, Huskić A Izvješće o osobama liječenim zbog zlouporabe psihoaktivnih droga u Hrvatskoj u 2015. godini [Report on persons treated for drug abuse in Croatia in 2015]. Hrvatski zavod za javno zdravstvo; 2015. Available from: http://www.hzjz.hr/sluzbe/sluzba-za-epidemiologiju/odjel-za-nadzor-i-istrazivanje-ne-zaraznih-bolesti/odsjek-za-pracenje-ovisnosti-s-registrom-osoba-lijecenih-zbog-zlouporabe-psihoaktivnih-droga/
   Google Scholar
• Gillström A, Wettermark B Literature review cross-national comparison of DU activities. For the Scientific Committee of the ISPE/EuroDurg meeting in Antwerp 2011*. EuroDURG/ISPE Meet; 2011.
   Google Scholar
• Vlahović-Palčevski V, Wettermark B, Ibáñez L, et al. Comparison of drug utilization across different geographical areas Chapter 14. In: M. Elseviers, B. Wettermark, A. Birna Almarsdóttir et al., editor. Drug utilization research: methods and applications. 1st ed.
   Google Scholar
• World Bank Data. 2006. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/378834-how-does-the-world-bank-classify-countries. [cited 2017 Aug].
   Google Scholar
• Ostroški L. Census of population, households and dwellings 2011, population by sex and age. Croatian Bureau of Statistics. 2013. [cited 2017 Aug]. Available from: http://www.dzs.hr/.
   Google Scholar
• Vogler S, Habl C, Bogut M, et al. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States. Croat Med J. 2011;52:183–197.
   PubMed Web of Science ®Google Scholar
• Godman B, Wettermark B, Hoffmann M, et al. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res. 2009;9(1):65–83.
   PubMedGoogle Scholar
• HALMED. Ukupna potrošnja lijekova u 2014. Godini. 2014. [cited 2017 Aug]. Available from: http://www.halmed.hr/Promet-proizvodnja-i-inspekcija/Promet/Potrosnja-lijekova/Izvjesca-o-prometu-lijekova/
   Google Scholar
• HALMED. Ukupna potrošnja lijekova u 2015. Godini. 2015. [cited 2017 Aug]. Available from: http://www.halmed.hr/Promet-proizvodnja-i-inspekcija/Promet/Potrosnja-lijekova/Izvjesca-o-prometu-lijekova/
   Google Scholar
• Swedish eHealth agency. [cited 2017 Aug]. Available from: https://www.ehalsomyndigheten.se/other-languages/english/
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. [cited 2018 Jun 30]. Available from: https://www.whocc.no/ddd/definition_and_general_considera/
   Google Scholar
• Salvesen Blix H. Measurement units of drug utilization. Chapter. In M. Elseviers, B. Wettermark, A. Birna Almarsdóttir et al., editors. Drug utilization research – methods and applications.
   Google Scholar
• Vlastelica M, Jelaska M. Zašto su benzodiazepine još uvijek u širokoj primjeni? Acta med Croat. 2012;66:137–140.
   PubMedGoogle Scholar
• Arbanas G, Arbanas D, Dujam K. Adverse effects of benzodiazepines in psychiatric outpatients. Psychiatr Danub. 2009;21(1):103–107.
   PubMed Web of Science ®Google Scholar
• Uzun S, Kozumplik O. Reinforcement of irritability during therapy with benzodiazepines. Psychiatr Danub. 2011;23(1):129–130.
   PubMed Web of Science ®Google Scholar
• Uzun S, Kozumplik O, Jakovljević M, et al. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010;22(1):90–93.
   PubMed Web of Science ®Google Scholar
• Ćurković M, Dodig-Ćurković K, Petek Erić A, et al. Psychotropic medications in older adults: a review. Psychiatr Danub. 2016;28(1):13–24.
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C, Sanz EJ. Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists. Med Sci Monit. 2004;10(7):CR288–CR293.
   PubMed Web of Science ®Google Scholar
• Štimac D, Čulig J. Outpatient utilization of psychopharmaceuticals in the city of Zagreb 2001–2006. Psychiatr Danub. 2009;21(1):56–64.
   PubMed Web of Science ®Google Scholar
• Vlahović-Palčevski V, Bergman U. Quality of prescribing for the elderly in Croatia - computerized pharmacy data can be used to screen for potentially inappropriate prescribing. Eur J Clin Pharmacol. 2004;60:217–220.
   PubMed Web of Science ®Google Scholar
• Živković K, Zelić-Kerep A, Štimac D, et al. A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006–2009. Coll Antropol. 2014;38(2):717–724.
   PubMedGoogle Scholar
• Kiivet RA, Bergman U, Rootslane L, et al. Drug use in Estonia in 1994–1995: a follow-up from 1989 and comparison with two Nordic countries. Eur J Clin Pharmacol. 1998;54(2):119–124.
   PubMed Web of Science ®Google Scholar
• Jordanova V, Maric NP, Alikaj V, et al. Prescribing practices in psychiatric hospitals in Eastern Europe. Eur Psychiatry. 2011;26(7):414–418.
   PubMed Web of Science ®Google Scholar
• Lenander C, Bondesson Å, Viberg N, et al. Effects of an intervention (SÄKLÄK) on prescription of potentially inappropriate medication in elderly patients. Family Practice. 2016;1–6. DOI:10.1093/fampra/cmw121
   PubMed Web of Science ®Google Scholar
• Järbrink K, Carlsten A, Frederiksen SO. Swedish physicians’ inclination to prescribe benzodiazepines: differences between regions and characteristics of the prescriber. Scand J Public Health. 1999;1:22–29.
   Web of Science ®Google Scholar
• World Health Organization. Depression and other common mental disorders: global health estimates. Rep. CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2017.
   Google Scholar
• World Population Review. Countries by median age. 2018. [cited 2018 Jun 28]. Available from: http://worldpopulationreview.com/countries/median-age/Accessed.
   Google Scholar